3.82
Omniab Inc (OABI) 最新ニュース
OmniAb Jumps 18% as Lilly Deal Lifts Cash Outlook - TradingView
Eli Lilly Signs $370 Million Ion Channel Deal With OmniAb, Sending Shares Surging - finance.biggo.com
OABI Reiterates by HC Wainwright & Co. -- Price Target Maintained at $11.00 - GuruFocus
Lilly taps OmniAb for ion channel discovery in deal worth up to USD 370m - AllSci
Lilly to pay up to $370M for OmniAb collab; Slate, Fulcrum forge reverse merger - Endpoints News
OmniAb Raises 2026 Financial Guidance - BioSpace
OmniAb Inc. (OABI) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
OmniAb (OABI) Stock Pops As Earnings Beat Resets Growth Outlook - timothysykes.com
Why Is Omniab Stock Rallying After Eli Lilly Deal? - Benzinga
OmniAb (OABI) Stock Surges After Big Q2 Earnings Beat - StocksToTrade
OABI Looks 15.8% Overvalued on GF Value™ - GuruFocus
OmniAb (OABI) Jumps As Earnings Beat Fuels Bullish Outlook - StocksToTrade
Why is OmniAb stock surging today? By Investing.com - Investing.com Canada
Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vague - Fierce Biotech
Why is OmniAb stock surging today? - Investing.com
OmniAb raises 2026 cash guidance to $49-$53 million range - scanx.trade
OmniAb lifts 2026 cash outlook following licensing momentum - Yahoo Finance
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company - Finviz
OmniAb partners with Eli Lilly on ion channel program By Investing.com - Investing.com Canada
OmniAb raises 2026 cash guidance on licensing activity - Investing.com
Whitefort Capital group reports 7.1% OmniAb (OABI) ownership in amended filing - Stock Titan
OmniAb (OABI) Q2 2026 Earnings Call Transcript - AOL.com
Dimensional Fund Advisors LP Has $2.74 Million Stake in OmniAb, Inc. $OABI - marketbeat.com
OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OABI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
New Forecasts: Here's What Analysts Think The Future Holds For OmniAb, Inc. (NASDAQ:OABI) - simplywall.st
OmniAb (NASDAQ:OABI) Sets New 1-Year HighTime to Buy? - MarketBeat
Is Now The Time To Look At Buying OmniAb, Inc. (NASDAQ:OABI)? - moomoo.com
HC Wainwright Forecasts OmniAb's Q3 Earnings (NASDAQ:OABI) - marketbeat.com
OmniAb Company Profile & Introduction - Moomoo
Price to sales forward of OmniAb, Inc. – NASDAQ:OABIW - TradingView
OmniAb (NASDAQ:OABI) Jumps After Strong Quarterly Update - Kalkine Media
OmniAb (NASDAQ:OABI) Issues Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $7 to $11 - moomoo.com
OmniAb (OABI) Stock Jumps As Milestones Cut Losses But Risks Linger - Sahm
Craig-Hallum Maintains OmniAb(OABI.US) With Buy Rating, Announces Target Price $7 - 富途牛牛
OmniAb, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:OABI) 2026-08-07 - Seeking Alpha
Stifel Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $9 - news.futunn.com
Truist Financial Maintains OmniAb(OABI.US) With Buy Rating - moomoo.com
OmniAb, Inc. (OABIW) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
OmniAb Inc (OABI) Stock News Today - tradingkey.com
OmniAb Inc reports results for the quarter ended June 30Earnings Summary - TradingView
OmniAb Q2 2026 slides: revenue surges on milestones, guidance raised By Investing.com - Investing.com South Africa
OmniAb Q2 2026 Earnings Call Transcript - MarketBeat
H.C. Wainwright Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights - BioSpace
OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $3 - Moomoo
OmniAb Q2 Earnings Call Highlights - TradingView
OmniAb Inc (OABI) (Q2 2026) Earnings Call Highlights: Revenue Surges 243% as Two Programs Leap ... - Yahoo Finance
Earnings call transcript: OmniAb beats Q2 2026 estimates and lifts outlook - Investing.com
OmniAb, Inc. (OABI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
OABI: Revenue growth and clinical progress drove improved outlook and reduced net loss - TradingView
OmniAb Q2 2026 slides: revenue surges on milestones, guidance raised - Investing.com
OABI: Strong Q2 revenue growth and raised 2026 guidance reflect robust partner and technology momentum - TradingView
OmniAb Q2 2026 slides: revenue surges 244%, guidance raised - Investing.com
OmniAb Q2 revenue beats analyst estimates, outlook raised - TradingView
OmniAb, Inc. 1H 2026: Revenue $27.8M, EPS ($0.05) — 10-Q Summary - TradingView
OmniAb (NASDAQ: OABI) grows partner base and cuts cash burn in 2026 - Stock Titan
OmniAb Reports Q2 2026 Revenue $13.4M, Narrows Full-Year Revenue to $32M–$36M - TradingView
OmniAb (NASDAQ: OABI) boosts 2026 revenue guidance after strong Q2 - Stock Titan
OABI: Q2 2026 delivered revenue growth, improved losses, and raised guidance amid strong partner momentum - TradingView
Omniab, Inc. Revises Earnings Guidance for the Year 2026 - marketscreener.com
OmniAb Q2 2026 slides: revenue surges 244%, guidance raised By Investing.com - Investing.com South Africa
Earnings To Watch: OmniAb Inc (OABI) Q2 2026 -- GF Value Sees 54% Upside - Yahoo Finance
大文字化:
|
ボリューム (24 時間):